In collaboration with you, we will focus on our mission of “Creating for Tomorrow” and accelerate the research and development of next-generation drugs that can contribute to the treatment of bone and cartilage diseases.
Answers for a meaningful life.
4-1-1. Refractory diseases with ossification of soft tissues, such as muscles, ligaments, tendons (e.g., Posterior longitudinal ligament ossification (OPLL) and Ossification of Ligamentum Flavum (OLF))
Research interests:
Out of interest:
Other conditions:
Click “Apply” to proceed to the application form.